Contact
searchSearch
HMP Global
Quiz

Inflammation in Axial Spondyloarthritis

Priyam Vora, Associate Editor

11/02/2023
© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Rheumatology and Arthritis Learning Network or HMP Global, their employees, and affiliates. 

Related Content

News
ASAS Issues Consensus Recommendations for Imaging in axSpA
10/10/2024
Rebecca Mashaw
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines...
10/10/2024
Rheumatology & Arthritis
News
Study Identifies Most Discriminative Ultrasound Lesions for Spondyloarthritis
09/11/2024
Jolynn Tumolo
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was...
09/11/2024
Rheumatology & Arthritis
News
SpA Screening Tools Not Applicable to All Patients With Extramusculoskeletal Symptoms
05/08/2024
Jolynn Tumolo
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
A scoping review of screening...
05/08/2024
Rheumatology & Arthritis
News
Patient-Reported Outcomes in Ankylosing Spondylitis Correlate With Work Productivity
02/26/2024
Jolynn Tumolo
Controlling pain and disease activity helps to improve productivity.
Controlling pain and disease activity helps to improve productivity.
Controlling pain and disease...
02/26/2024
Rheumatology & Arthritis

Popular Articles

News
Study Identifies Most Discriminative Ultrasound Lesions for Spondyloarthritis
09/11/2024
Jolynn Tumolo
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was...
09/11/2024
Rheumatology & Arthritis
News
SpA Screening Tools Not Applicable to All Patients With Extramusculoskeletal Symptoms
05/08/2024
Jolynn Tumolo
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
A scoping review of screening...
05/08/2024
Rheumatology & Arthritis
News
ASAS Issues Consensus Recommendations for Imaging in axSpA
10/10/2024
Rebecca Mashaw
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines...
10/10/2024
Rheumatology & Arthritis
Len Calabrese
Podcast
Leonard Calabrese, DO, on the Nosology of Long COVID
02/29/2024
Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.
Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.
Dr Leonard Calabrese of the...
02/29/2024
Rheumatology & Arthritis
News
IL-17 and IL-23 Inhibitor Infection Risk Low in PsA, PsO
03/04/2024
Priyam Vora
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the...
03/04/2024
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use